News tagged with allergan

Related topics: food and drug administration

Actavis plans name change to Allergan

Drugmaker Actavis is planning to change its name as it draws closer to finishing another big deal, the $66 billion purchase of Botox maker Allergan that it announced last fall.

Feb 18, 2015
popularity 2 comments 0

US family gets $6.75 million in Botox case

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

Nov 20, 2014
popularity 0 comments 0

Actavis to spend $66 billion on Allergan

Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.

Nov 17, 2014
popularity 0 comments 0

Valeant pitches potential eye drug, research focus

Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.

Sep 25, 2014
popularity 0 comments 0

Valeant Pharma expects 3Q revenue to top forecasts

Shares of Valeant Pharmaceuticals International Inc. climbed Wednesday after the Canadian drugmaker said it expects market share gains in most of its businesses and that its third-quarter revenue will top forecasts.

Sep 24, 2014
popularity 0 comments 0

Valeant planning hostile bid for Allergan

Valeant plans to take a buyout offer for Allergan directly to its shareholders this week, as the Botox maker continues to rebuff its proposals that have risen as high as $53 billion.

Jun 17, 2014
popularity 0 comments 0

Allergan

Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products.

This text uses material from Wikipedia licensed under CC BY-SA